EBioMedicine

The effective translation of insights gained from biomedical research into improved human health is a global priority. To this end, Elsevier has looked to the leadership of its two leading brands, Cell and The Lancet, to guide the launch of a new comprehensive, online-only open access Elsevier journal, EBioMedicine, focused on forming a community that spans this interface and creates a valuable opportunity for dialogue and collaboration between their respective audiences.

Publisher
Elsevier
Website
http://www.ebiomedicine.com/

Some content from Wikipedia, licensed under CC BY-SA

Medical research

Researchers discover how to slow aging

Previous research published earlier this year in Nature Medicine involving University of Minnesota Medical School faculty Paul D. Robbins and Laura J. Niedernhofer and Mayo Clinic investigators James L. Kirkland and Tamara ...

Health

Common disinfectant may lead to superbug mutation

We tend to think of disinfectants as our allies in the fight against disease, a feeling that may never have been stronger than during the COVID-19 pandemic. But now a groundbreaking Macquarie University study has found a ...

Diseases, Conditions, Syndromes

COVID-19 vaccine candidate shows promise in first peer-reviewed research

University of Pittsburgh School of Medicine scientists today announced a potential vaccine against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic. When tested in mice, the vaccine, delivered through a fingertip-sized ...

HIV & AIDS

Researchers make first steps toward a cure for HIV

Researchers have developed a way to pull HIV out of the latent reservoir making the virus visible to the immune system and providing the potential to be killed by treatment.

Oncology & Cancer

Radio-wave therapy proves effective against liver cancer cells

A new targeted therapy using non-thermal radio waves has been shown to block the growth of liver cancer cells anywhere in the body without damaging healthy cells, according to a study conducted by scientists at Wake Forest ...

Diseases, Conditions, Syndromes

First-in-human trial of senolytic drugs encouraging

UT Health San Antonio researchers, collaborating with the Mayo Clinic and the Wake Forest School of Medicine, are the first to publish results on the treatment of a deadly age-related disease in human patients with drugs ...

page 1 from 30